Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
16.51
-2.36 (-12.51%)
At close: Oct 10, 2025, 4:00 PM EDT
16.31
-0.20 (-1.21%)
After-hours: Oct 10, 2025, 7:46 PM EDT
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $317.18 million as of October 10, 2025. Its market cap has decreased by -8.23% in one year.
Market Cap
317.18M
Enterprise Value
75.43M
1-Year Change
-8.23%
Ranking
Category
Stock Price
$16.51
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $317.18M, a decrease of -92.32%. That is a compound annual growth rate of -44.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 317.18M | 69.63% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | 4.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |